Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey-Reference-Cited by-同舟云学术

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey

Published:2024-02-18 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Wang Qiang¹,Xiu Shixin²,Yang Liuqing³⁴,Li Lan⁴,Yang Min²,Wang Xuwen²,Shen Yuan²,Wang Weibing¹,Lin Leesa⁵⁶⁷

Affiliation:

1. Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China

2. Department of Immunization, Wuxi Center for Disease Control and Prevention, Wuxi, China

3. Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China

4. Centre for Digital Public Health in Emergencies, Institute for Risk and Disaster Reduction, University College London, London, UK

5. Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK

6. Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China

7. WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China

Funder

Medical Development discipline Foundation of Wuxi

Innovation and Technology Commission

Shanghai Municipal Science and Technology Major Project

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2310916

Reference28 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

2. Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis

3. The disease burden of respiratory syncytial virus in Infants

4. Centers for Disease Control and Prevention. Respiratory Syncytial Virus (RSV) immunizations. [accessed 2023 Sept 26]. https://www.cdc.gov/vaccines/vpd/rsv/index.html.

5. U.S. FOOD & DRUG. FDA approves first vaccine for pregnant individuals to prevent RSV in infants. [accessed 2023 Sept 26].https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing the role of eHealth literacy in shaping popular attitudes towards post-COVID-19 vaccination among Chinese adults;Humanities and Social Sciences Communications;2024-09-05

2. Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel;Human Vaccines & Immunotherapeutics;2024-08-19

3. Simultaneous vaccination against seasonal influenza and COVID-19 among the target population in Italy;Frontiers in Public Health;2024-08-06